Soc. Generale Knock-Out MRK/ DE000SF5JH45 /
5/10/2024 9:41:49 PM | Chg.+0.01 | Bid10:00:36 PM | Ask10:00:36 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.58EUR | +0.22% | - Bid Size: - |
- Ask Size: - |
Merck and Co Inc | 81.4119 USD | 12/31/2078 | Call |
GlobeNewswire
5/8
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
4/24
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Onc...
GlobeNewswire
4/15
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire
4/9
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer...
GlobeNewswire
3/18
Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D...
GlobeNewswire
3/15
American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...
GlobeNewswire
3/6
IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...
GlobeNewswire
2/7
Alleo Labs Announces Publication on the Use of Artificial Intelligence in Neuroscience Drug Discover...
GlobeNewswire
1/9
C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted ...
GlobeNewswire
12/21/2023
IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial
GlobeNewswire
12/4/2023
Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule